Coronavirus updates: State reports over 49,000 new cases, 468 new deaths

Rollout of a COVID-19 vaccine developed by England's University of Oxford and British-Swedish pharmaceutical company AstraZeneca began in the United Kingdom on Monday morning.

Brian Pinker, an 82-year-old dialysis patient, was the first person in the country -- and the world -- to receive the newly approved vaccine outside of a clinical trial, according to a press release from National Health Service (NHS) England. He told reporters that he felt "pretty good" after getting the shot at Churchill Hospital in Oxford, England.

"I am so pleased to be getting the COVID vaccine today and really proud that it is one that was invented in Oxford," Pinker, who was born and raised in Oxford, said in a statement released by NHS England. "The nurses, doctors and staff today have all been brilliant and I can now really look forward to celebrating my 48th wedding anniversary with my wife Shirley later this year."

Trevor Cowlett, an 88-year-old music teacher and father of three, and Dr. Andrew Pollard, director of the Oxford Vaccine Group and chief investigator into the clinical trial of the shot, were also among the first to get the jab Monday.

"It was an incredibly proud moment for me to have received the actual vaccine that the University of Oxford and the AstraZeneca teams have worked so hard to make available to the UK and the world," Pollard said in a statement released by NHS England. "As a pediatrician specialising in infections, I know how important it is that health care workers along with other priority groups are protected as soon as possible -- a crucial role in defeating this terrible disease."

NHS England said the Oxford/AstraZeneca vaccine will be delivered to a small number of U.K. hospitals for the first few days for "surveillance purposes, as is standard practice, before the bulk of supplies are send to hundreds of GP-led services later in the week." Hundreds of new vaccination sites are set to open this week, in addition to the 700 already in operation.

The U.K. became the first country to approve the Oxford/AstraZeneca vaccine for emergency supply last week. Another COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech was authorized in the U.K. on Dec. 2 and rollout began a week later. Both vaccines are administered in two doses.

There were 210,479 new cases of COVID-19 confirmed in the United States on Sunday, according to a real-time count kept by Johns Hopkins University.

It's the second straight day that the country has reported more than 200,000 newly confirmed infections. Sunday's tally is less than the all-time high of 297,491 new cases, which the country logged the previous day, Johns Hopkins data shows.

An additional 1,396 deaths from COVID-19 were also registered nationwide on Sunday, down from a peak of 3,750 on Dec. 30, according to Johns Hopkins data.

COVID-19 data may be skewed due to possible lags in reporting over the holidays followed by a potentially very large backlog.

A total of 20,637,537 people in the U.S. have been diagnosed with COVID-19 since the pandemic began, and at least 351,580 of them have died, according to Johns Hopkins data. The cases include people from all 50 U.S. states, Washington, D.C., and other U.S. territories as well as repatriated citizens.

Much of the country was under lockdown by the end of March as the first wave of pandemic hit. By May 20, all U.S. states had begun lifting stay-at-home orders and other restrictions put in place to curb the spread of the novel coronavirus. The day-to-day increase in the country's cases then hovered around 20,000 for a couple of weeks before shooting back up over the summer.

The numbers lingered around 40,000 to 50,000 from mid-August through early October before surging again to record levels, crossing 100,000 for the first time on Nov. 4 and reaching 200,000 for the first time on Nov. 27.